Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 1
2009 1
2010 2
2012 1
2013 1
2016 2
2017 2
2018 2
2019 4
2020 1
2021 5
2022 7
2023 10
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean ma feng mao (1 results)?
Development and validation of a radiomics-based nomogram for predicting a major pathological response to neoadjuvant immunochemotherapy for patients with potentially resectable non-small cell lung cancer.
Liu C, Zhao W, Xie J, Lin H, Hu X, Li C, Shang Y, Wang Y, Jiang Y, Ding M, Peng M, Xu T, Hu A, Huang Y, Gao Y, Liu X, Liu J, Ma F. Liu C, et al. Among authors: ma f. Front Immunol. 2023 Feb 16;14:1115291. doi: 10.3389/fimmu.2023.1115291. eCollection 2023. Front Immunol. 2023. PMID: 36875128 Free PMC article. Clinical Trial.
Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinoma.
Luo B, Ma F, Liu H, Hu J, Rao L, Liu C, Jiang Y, Kuangzeng S, Lin X, Wang C, Lei Y, Si Z, Chen G, Zhou N, Liang C, Jiang F, Liu F, Dai W, Liu W, Gao Y, Li Z, Li X, Zhou G, Li B, Zhang Z, Nian W, Luo L, Liu X. Luo B, et al. Among authors: ma f. BMC Med. 2022 Jan 14;20(1):8. doi: 10.1186/s12916-021-02201-3. BMC Med. 2022. PMID: 35027051 Free PMC article.
Tumor regression rate, PD-L1 expression, pembrolizumab/nab-paclitaxel-based regimens, squamous cell carcinoma, and comorbidities were independently associated with efficacy of neoadjuvant chemoimmunotherapy in non-small cell lung cancer.
Hu X, Hu C, Liu X, Ma F, Xie J, Zhong P, Tang C, Fan D, Gao Y, Feng X, Ding M, Li D, Liu C. Hu X, et al. Among authors: ma f. Front Oncol. 2023 Jan 27;12:1057646. doi: 10.3389/fonc.2022.1057646. eCollection 2022. Front Oncol. 2023. PMID: 36776373 Free PMC article.
37 results